Day: April 7, 2026

us corporate news

Bluejay Diagnostics Nears Completion of SYMON-II Clinical Trial with 624 Patient Enrollments for Symphony IL-6 Sepsis Test

Minichart

April 7, 2026

Bluejay Diagnostics Reaches Key Enrollment Milestone in SYMO...

Continue Reading 0

us corporate news

TriSalus Life Sciences, Inc. Files Form 8-K on April 1, 2026 Announcing Press Release and Company Information

Minichart

April 7, 2026

TriSalus Life Sciences Announces Appointment of Chief Medica...

Continue Reading 0

us corporate news

Blackstone and TPG Acquire Hologic for $79 Per Share, Appoint Joe Almeida as CEO

Minichart

April 7, 2026

Blackstone and TPG Complete \$7B+ Acquisition of Hologic, Ap...

Continue Reading 0

us corporate news

TransDigm Group Completes $2.2 Billion Acquisition of Jet Parts Engineering and Victor Sierra Aviation Holdings

Minichart

April 7, 2026

TransDigm Completes Acquisition of Jet Parts Engineering and...

Continue Reading 0

us corporate news

Haymaker Acquisition Corp. 4 Non-Redemption Agreement: Terms, Shareholder Obligations, and Payment Details for Business Combination 1

Minichart

April 7, 2026

Haymaker Acquisition Corp. 4: Non-Redemption Agreement Detai...

Continue Reading 0

us corporate news

SolarMax Technology Reports 296% Revenue Growth and Major EPC Contract Wins in Fiscal Year 2025 Financial Results

Minichart

April 7, 2026

SolarMax Technology, Inc. Reports Explosive Revenue Growth a...

Continue Reading 0

us corporate news

Chemung Financial Corporation Files Form 8-K with NASDAQ Listing and Company Details (April 3, 2026) 22

Minichart

April 7, 2026

NIL Disclaimer: This article is for informational purposes o...

Continue Reading 0

us corporate news

ZEO ScientifiX Advances to XPRIZE Healthspan Semi-Finals with Regenerative Biologics Platform 1

Minichart

April 7, 2026

ZEO ScientifiX Advances in \$101 Million XPRIZE Healthspan C...

Continue Reading 0

us corporate news

Cue Biopharma, Inc. Files Form 8-K SEC Report for April 2026 – Company Details, Stock Information, and Executive Signature

Minichart

April 7, 2026

Cue Biopharma, Inc. 8-K Filing - Investor Report Cue B...

Continue Reading 0

us corporate news

Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments

Minichart

April 7, 2026

Artelo Biosciences Regains Nasdaq Compliance and Advances Pi...

Continue Reading 0